Literature DB >> 8913376

Differences in heavy-ion-induced DNA double-strand breaks in a mouse DNA repair-deficient mutant cell line (SL3-147) before and after chromatin proteolysis.

M Murakami1, K Eguchi-Kasai, K Sato, S Minohara, F Yatagai, T Kanai.   

Abstract

DNA double-strand breaks induced by X- or neon beam-irradiation in a DNA double-strand break-repair-deficient mutant cell line (SL3-147) were examined. The increase in the number of DNA double-strand breaks was dose depend after irradiation with X-rays and neon beams and was enhanced by chromatin-proteolysis treatment before irradiation. These results suggest that the induction of DNA double-strand breaks by ionizing radiation, including heavy-ions, is influenced by the chromatin structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8913376     DOI: 10.1269/jrr.36.258

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  6 in total

1.  Adenovirus-mediated p53 gene transfer sensitizes hepatocellular carcinoma cells to heavy-ion radiation.

Authors:  Bing Liu; Hong Zhang; Guangming Zhou; Yi Xie; Jifang Hao; Rong Qiu; Xin Duan; Qingming Zhou
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

2.  In vitro evaluation of photon and carbon ion radiotherapy in combination with chemotherapy in glioblastoma cells.

Authors:  Stephanie E Combs; Lisa Zipp; Stefan Rieken; Daniel Habermehl; Stefan Brons; Marcus Winter; Thomas Haberer; Jürgen Debus; Klaus-Josef Weber
Journal:  Radiat Oncol       Date:  2012-01-27       Impact factor: 3.481

3.  In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines.

Authors:  Rami A El Shafie; Daniel Habermehl; Stefan Rieken; Andrea Mairani; Lena Orschiedt; Stefan Brons; Thomas Haberer; Klaus-Josef Weber; Jürgen Debus; Stephanie E Combs
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

4.  Particle radiation therapy in the management of malignant glioma: Early experience at the Shanghai Proton and Heavy Ion Center.

Authors:  Lin Kong; Jinsong Wu; Jing Gao; Xianxin Qiu; Jing Yang; Jiyi Hu; Weixu Hu; Ying Mao; Jiade J Lu
Journal:  Cancer       Date:  2020-03-13       Impact factor: 6.860

Review 5.  Safety and Local Control of Radiation Therapy for Chordoma of the Spine and Sacrum: A Systematic Review.

Authors:  Brenton Pennicooke; Ilya Laufer; Arjun Sahgal; Peter P Varga; Ziya L Gokaslan; Mark H Bilsky; Yoshiya J Yamada
Journal:  Spine (Phila Pa 1976)       Date:  2016-10-15       Impact factor: 3.241

6.  Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol.

Authors:  Matthias Uhl; Lutz Edler; Alexandra D Jensen; Gregor Habl; Jan Oelmann; Falk Röder; Oliver Jäckel; Jürgen Debus; Klaus Herfarth
Journal:  Radiat Oncol       Date:  2014-04-29       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.